Ramin Schadlu, MD
Ophthalmology · Phoenix, AZNPI 1962428276
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (57.5%), travel and lodging and entertainment — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Carl Zeiss Meditec, Inc. at 37.2% of the total. Reporting peaked in 2019 at $342 and has fallen 69.5% since, to $104 in 2025. That places this record below the midpoint for ophthalmology clinicians in AZ, where the typical reported total is $1,526.
Across 10 payments — averaging $61.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Carl Zeiss Meditec, Inc.$229
- Regeneron$200
- Dutch Ophthalmic, USA$113
- Alcon$41
- Optos, Inc.$18
- Regeneron Healthcare Solutions, Inc.$15
Across 384 payments — averaging $4808.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$1.2M
- Regeneron$255K
- Roche TCRC, Inc.$135K
- Hexal AG$76K
- Bayer$49K
- Novartis$27K
- plus $56K from 4 others
What the payments were for
- Travel & lodging$22937%
- Food & beverage$35458%
- Education$152%
- Entertainment$183%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Carl Zeiss Meditec, Inc. | 1 | $229 |
| Regeneron | 4 | $200 |
| Dutch Ophthalmic, USA | 1 | $113 |
| Alcon | 2 | $41 |
| Optos, Inc. | 1 | $18 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$615 in reported general payments places this provider in the 25th percentile of 310 ophthalmology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 116 | $6,205 |
| IlevroNepafenac | 16 | $6,053 |
| Ketorolac Tromethamine | 66 | $1,545 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 45 | $790 |
| Brimonidine Tartrate | 16 | $511 |
| Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim | 69 | $478 |
| Latanoprost | 17 | $102 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Phoenix
- Pravin DugelPhoenix$176K
- Nishi ShahPhoenix$92K
- Karim JamalPhoenix$72K
- Benjamin HellerPhoenix$41K
- Neal PalejwalaPhoenix$33K
- Joshua DuncanPhoenix$30K
- Sachin MehtaPhoenix$23K
- Daniel ChurginPhoenix$15K
- John CasonPhoenix$14K
- Sujit IttyPhoenix$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.